Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Dyne Therapeutics Inc (DYN)
Dyne Therapeutics Inc (DYN) Financials

DYN Dyne Therapeutics Inc

30.61

-0.52 (-1.67%)

29 Nov 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-116.376	-120.296	-32.148	-38.329	-45.929	-100.099
Return on Equity (%)	197.213	-324.539	-33.354	-42.02	-54.176	-137.31
Return on Invested Capital (%)	-229.316	-153.392	-33.142	-42.503	-55.513	-142.859
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	1.982	5.426	7.595	7.134	4.862	1.487
Earnings Per Share	-2.28	-5.744	-1.319	-2.893	-3.238	-3.844
Cash Per Share	3.85	5.656	6.674	3.891	3.316	1.982
Working Capital Per Share	3.529	4.794	7.501	6.853	4.576	1.275
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-2.28	-5.744	-1.319	-2.893	-3.238	-3.844
EBITDA Per Share	-2.28	-5.744	-1.319	-2.893	-3.238	-3.844
Free Cash Flow Per Share	-2.228	-5.212	-1.308	-2.844	-3.212	-3.86

Liquidity Ratios

Year End 31 December 2023	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	2.11M	2.59M	45.08M	N/A	N/A	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	51.91M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	3.17B
Price to Earnings Ratio	-13.2
Price to Sales Ratio	0
Price to Cash Ratio	25.61
Price to Book Ratio	34.12
Dividend Yield	-

Share Statistics

Shares Outstanding	101.77M
Average Volume (1 week)	1.12M
Average Volume (1 Month)	1.18M
52 Week Change	196.03%
52 Week High	47.45
52 Week Low	10.27

More Ratios Coming Soon!

Dyne Therapeutics

BNP Paribas Issuance BV

Arrowstar Resources

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions